Cytek Biosciences (CTKB) Gross Profit (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytek Biosciences | - | - | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.37% |
| Dec 31, 2025 | 19.36% |
| Sep 30, 2025 | 15.44% |
| Jun 30, 2025 | 18.41% |
| Mar 31, 2025 | -40.10% |
| Dec 31, 2024 | 16.02% |
| Sep 30, 2024 | 14.03% |
| Jun 30, 2024 | 10.53% |
| Mar 31, 2024 | -30.36% |
| Dec 31, 2023 | 21.60% |
| Sep 30, 2023 | -3.49% |
| Jun 30, 2023 | 33.86% |
| Mar 31, 2023 | -28.38% |
| Dec 31, 2022 | 9.35% |
| Sep 30, 2022 | 9.37% |
| Jun 30, 2022 | 21.73% |
| Mar 31, 2022 | -14.63% |
| Dec 31, 2021 | 11.09% |
| Sep 30, 2021 | 7.76% |
| Jun 30, 2021 | 36.30% |
| Mar 31, 2021 | -25.52% |
| Dec 31, 2020 | 24.55% |
| Sep 30, 2020 | 88.83% |